Ecstasy (MDMA) and other designer drugs
- 1 January 2013
- book chapter
- Published by Elsevier
- p. 665-673
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging studyBrain, 2010
- MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI studyJournal of Psychopharmacology, 2009
- Prior MDMA (Ecstasy) use is associated with increased basal ganglia–thalamocortical circuit activation during motor task performance in humans: An fMRI studyNeuroImage, 2009
- Neuroimaging in Human MDMA (Ecstasy) UsersAnnals of the New York Academy of Sciences, 2008
- Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performancePsychopharmacology, 2008
- Neuroimaging research in human MDMA users: a reviewPsychopharmacology, 2006
- Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASBNeuropsychopharmacology, 2005
- Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging studyBiological Psychiatry, 2004
- Functional MRI study of working memory in MDMA usersPsychopharmacology, 2004
- The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human BrainNeuropsychopharmacology, 2002